Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Graft Versus Host Disease With [18F]F-AraG, a Positron Emission Tomography Tracer for Activated T Cells

NCT03367962 is registered in ClinicalTrials.gov with CellSight Technologies, Inc. as lead sponsor.

NCT NCT03367962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03367962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Graft Versus Host Disease With [18F]F-AraG, a Positron Emission Tomography Tracer for Activated T Cells
Lead sponsor
CellSight Technologies, Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 15, 2018
Completion date
October 21, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease